| GS follow link to MSigDB | GS DETAILS | SIZE | ES | NES | NOM p-val | FDR q-val | FWER p-val | RANK AT MAX | LEADING EDGE | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CL8032, PROTEIN PHOSPHATASE TYPE 2A COMPLEX | Details ... | 18 | 0.68 | 1.42 | 0.011 | 0.341 | 0.297 | 961 | tags=22%, list=5%, signal=23% |
| 2 | CL8578, GLYCOLYSIS, AND SUGAR-PHOSPHATASE ACTIVITY | Details ... | 33 | 0.59 | 1.29 | 0.031 | 0.889 | 0.841 | 5496 | tags=55%, list=31%, signal=78% |
| 3 | CL2173, U2-TYPE CATALYTIC STEP 2 SPLICEOSOME | Details ... | 16 | 0.59 | 1.24 | 0.153 | 1.000 | 0.950 | 5265 | tags=50%, list=29%, signal=71% |
| 4 | CL10570, URIDINE-DIPHOSPHATASE ACTIVITY, AND PURINE RIBONUCLEOTIDE SALVAGE | Details ... | 17 | 0.60 | 1.23 | 0.126 | 0.814 | 0.965 | 3499 | tags=47%, list=19%, signal=58% |
| 5 | CL10567, PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS, AND URIDINE-DIPHOSPHATASE ACTIVITY | Details ... | 28 | 0.57 | 1.23 | 0.099 | 0.671 | 0.970 | 6003 | tags=57%, list=33%, signal=86% |
| 6 | CL5104, NPBAF COMPLEX, AND H3K9ME3 MODIFIED HISTONE BINDING | Details ... | 15 | 0.58 | 1.19 | 0.193 | 0.799 | 0.994 | 1208 | tags=13%, list=7%, signal=14% |
| 7 | CL23065, IONOTROPIC GLUTAMATE RECEPTOR, AND NEUROTRANSMITTER RECEPTOR TRANSPORT, POSTSYNAPTIC ENDOSOME TO LYSOSOME | Details ... | 16 | 0.58 | 1.19 | 0.187 | 0.686 | 0.994 | 3559 | tags=31%, list=20%, signal=39% |
| 8 | CL8029, MAGNESIUM-DEPENDENT PROTEIN SERINE|THREONINE PHOSPHATASE COMPLEX, AND CALCIPRESSIN | Details ... | 36 | 0.53 | 1.17 | 0.148 | 0.753 | 1.000 | 1819 | tags=17%, list=10%, signal=19% |
| 9 | CL4976, MLL3|4 COMPLEX, AND HISTONE H3-K4 DIMETHYLATION | Details ... | 16 | 0.55 | 1.16 | 0.252 | 0.708 | 1.000 | 1581 | tags=19%, list=9%, signal=21% |
| 10 | CL5099, SWI|SNF COMPLEX | Details ... | 30 | 0.53 | 1.15 | 0.195 | 0.681 | 1.000 | 2085 | tags=13%, list=12%, signal=15% |
| 11 | CL8579, FRUCTOSE AND MANNOSE METABOLISM | Details ... | 19 | 0.55 | 1.14 | 0.225 | 0.642 | 1.000 | 5496 | tags=53%, list=31%, signal=76% |
| 12 | CL2170, U2-TYPE CATALYTIC STEP 2 SPLICEOSOME, AND SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | Details ... | 23 | 0.53 | 1.14 | 0.252 | 0.609 | 1.000 | 2941 | tags=30%, list=16%, signal=36% |
| 13 | CL2040, U2-TYPE PRECATALYTIC SPLICEOSOME | Details ... | 24 | 0.52 | 1.11 | 0.293 | 0.691 | 1.000 | 4112 | tags=33%, list=23%, signal=43% |
| 14 | CL17673, MIXED, INCL. INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS, AND CARDIOFACIOCUTANEOUS SYNDROME | Details ... | 25 | 0.52 | 1.10 | 0.311 | 0.706 | 1.000 | 2674 | tags=24%, list=15%, signal=28% |
| 15 | CL10681, INTERCONVERSION OF NUCLEOTIDE DI- AND TRIPHOSPHATES, AND UTP METABOLIC PROCESS | Details ... | 22 | 0.51 | 1.08 | 0.337 | 0.719 | 1.000 | 372 | tags=14%, list=2%, signal=14% |
| 16 | CL25156, NUCLEOTIDE RECEPTOR ACTIVITY | Details ... | 17 | 0.52 | 1.08 | 0.356 | 0.696 | 1.000 | 2876 | tags=29%, list=16%, signal=35% |
| 17 | CL2038, PRECATALYTIC SPLICEOSOME, AND U4|U6 X U5 TRI-SNRNP COMPLEX | Details ... | 41 | 0.48 | 1.07 | 0.345 | 0.704 | 1.000 | 4112 | tags=29%, list=23%, signal=38% |
| 18 | CL22979, NEUROTRANSMITTER RECEPTOR COMPLEX, AND NEUREXINS AND NEUROLIGINS | Details ... | 72 | 0.46 | 1.04 | 0.361 | 0.749 | 1.000 | 1615 | tags=14%, list=9%, signal=15% |
| 19 | CL5268, ISWI-TYPE COMPLEX, AND BRK DOMAIN | Details ... | 19 | 0.49 | 1.02 | 0.470 | 0.819 | 1.000 | 4040 | tags=26%, list=22%, signal=34% |
| 20 | CL2035, U2-TYPE SPLICEOSOMAL COMPLEX, AND MRNA SPLICING - MAJOR PATHWAY | Details ... | 97 | 0.44 | 1.01 | 0.462 | 0.789 | 1.000 | 4281 | tags=27%, list=24%, signal=35% |
| 21 | CL2036, SPLICEOSOMAL SNRNP COMPLEX, AND MRNA CIS SPLICING, VIA SPLICEOSOME | 60 | 0.44 | 0.99 | 0.531 | 0.826 | 1.000 | 4281 | tags=28%, list=24%, signal=37% | |
| 22 | CL17474, PHOSPHATIDYLINOSITOL 3-KINASE COMPLEX, CLASS I, AND INSULIN RECEPTOR COMPLEX | 18 | 0.46 | 0.97 | 0.560 | 0.854 | 1.000 | 5792 | tags=44%, list=32%, signal=65% | |
| 23 | CL21442, CANONICAL AND NON-CANONICAL NOTCH SIGNALING, AND FRINGE | 23 | 0.44 | 0.95 | 0.598 | 0.885 | 1.000 | 3674 | tags=26%, list=20%, signal=33% | |
| 24 | CL21437, MIXED, INCL. NOTCH SIGNALING PATHWAY, AND AMYLOID A4 | 57 | 0.42 | 0.95 | 0.639 | 0.856 | 1.000 | 6875 | tags=42%, list=38%, signal=68% | |
| 25 | CL17473, MIXED, INCL. SIGNALING BY ERYTHROPOIETIN, AND INSULIN RECEPTOR COMPLEX | 33 | 0.43 | 0.94 | 0.649 | 0.837 | 1.000 | 5958 | tags=42%, list=33%, signal=63% | |
| 26 | CL22980, NEUREXINS AND NEUROLIGINS, AND REGULATION OF PRESYNAPSE ASSEMBLY | 36 | 0.41 | 0.91 | 0.693 | 0.874 | 1.000 | 1033 | tags=8%, list=6%, signal=9% | |
| 27 | CL17470, GPVI-MEDIATED ACTIVATION CASCADE, AND SH2 DOMAIN SUPERFAMILY | 62 | 0.39 | 0.88 | 0.827 | 0.919 | 1.000 | 5958 | tags=37%, list=33%, signal=55% | |
| 28 | CL17509, DOWNSTREAM SIGNAL TRANSDUCTION, AND GRB2-ASSOCIATED-BINDING PROTEIN 1-4-LIKE | 15 | 0.40 | 0.83 | 0.773 | 0.973 | 1.000 | 5958 | tags=40%, list=33%, signal=60% | |
| 29 | CL18402, MIXED, INCL. MAP KINASE ACTIVITY, AND PROTEIN TYROSINE|THREONINE PHOSPHATASE ACTIVITY | 30 | 0.37 | 0.81 | 0.855 | 0.969 | 1.000 | 5587 | tags=30%, list=31%, signal=43% | |
| 30 | CL13677, TRAPP COMPLEX | 15 | 0.36 | 0.74 | 0.873 | 1.000 | 1.000 | 11505 | tags=80%, list=64%, signal=222% | |
| 31 | CL10910, NICOTINATE AND NICOTINAMIDE METABOLISM | 15 | 0.35 | 0.72 | 0.900 | 0.994 | 1.000 | 7840 | tags=47%, list=44%, signal=83% | |
| 32 | CL34187, DESMOSOME, AND ICHTHYOSIS VULGARIS | 24 | 0.30 | 0.63 | 0.972 | 1.000 | 1.000 | 10450 | tags=63%, list=58%, signal=149% | |
| 33 | CL22984, NEUREXINS AND NEUROLIGINS | 20 | 0.24 | 0.52 | 0.995 | 0.994 | 1.000 | 1033 | tags=5%, list=6%, signal=5% |